J Bruff - Varian Medical President

President

J Bruff is Chief Financial Officer, Senior Vice President - Finance of Varian Medical Systems since 2021.
Age 50
Tenure 4 years
Phone650 493-4000
Webwww.varian.com

Varian Medical Management Efficiency

The company has Return on Asset of 5.92 % which means that on every $100 spent on assets, it made $5.92 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 13.51 %, implying that it generated $13.51 on every 100 dollars invested. Varian Medical's management efficiency ratios could be used to measure how well Varian Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Varian Medical Systems has 350.5 M in debt with debt to equity (D/E) ratio of 0.16, which may show that the company is not taking advantage of profits from borrowing. Varian Medical Systems has a current ratio of 1.48, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Varian to invest in growth at high rates of return.

Similar Executives

Found 10 records

PRESIDENT Age

Julie AverillLululemon Athletica
54
Jamie BeggsAvient Corp
48
Brian DickmanGetty Realty
49
Michelle ChoeLululemon Athletica
55
Mark OlearGetty Realty
61
Celeste BurgoyneLululemon Athletica
51
Joshua DickerGetty Realty
60
Vinod PurayathAvient Corp
45
Danion FieldingGetty Realty
47
John FlorsheimWeyco Group
61
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company was founded in 1948 and is headquartered in Palo Alto, California. Varian Medical operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10000 people. Varian Medical Systems (VAR) is traded on New York Stock Exchange in USA and employs 10,000 people.

Management Performance

Varian Medical Systems Leadership Team

Elected by the shareholders, the Varian Medical's board of directors comprises two types of representatives: Varian Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Varian. The board's role is to monitor Varian Medical's management team and ensure that shareholders' interests are well served. Varian Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Varian Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeffrey Balser, Independent Director
R Eckert, Independent Chairman of the Board
Regina Dugan, Independent Director
David Illingworth, Independent Director
Judy Bruner, Independent Director
Kolleen Kennedy, Executive Vice President, President - Proton Solutions Division and Chief Growth Officer
J Bruff, Chief Financial Officer, Senior Vice President - Finance
Christopher Toth, President, Chief Executive Officer, Chief Operating Officer
Michael Hutchinson, Senior Vice President, Chief Legal Officer, Corporate Secretary
Anat Ashkenazi, Independent Director
Phillip Febbo, Chief Medical Officer, Director
JeanLuc Butel, Independent Director
Kevin OReilly, Senior Vice President and President Oncology Systems
Chris Toth, President - Varian Oncology Systems
Dow Wilson, President, Chief Executive Officer, Director
Michelle Beau, Independent Director
Francis Facchini, President Interventional Solutions Business

Varian Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Varian Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Varian Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Varian Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Varian Medical will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Hess could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hess when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hess - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hess Corporation to buy it.
The correlation of Hess is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hess moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hess moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hess can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Consideration for investing in Varian Stock

If you are still planning to invest in Varian Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Varian Medical's history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity